Current Report Filing (8-k)
May 13 2015 - 6:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant
to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 6, 2015
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
1-31719 |
|
13-4204626 |
(State of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification Number) |
200 Oceangate, Suite 100, Long Beach, California 90802
(Address of principal executive offices)
Registrants telephone number, including area code: (562) 435-3666
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. |
Submission of Matters to a Vote of Security Holders. |
On May 6, 2015, Molina Healthcare, Inc., a
Delaware corporation (the Company), held its 2015 Annual Meeting of Stockholders. At the meeting, a total of 46,804,638 shares were voted, representing 93.8% of the 49,918,906 shares outstanding as of the March 17, 2015
record date.
At the Companys 2015 Annual Meeting of Stockholders, the stockholders:
|
(1) |
elected all three of the Companys nominees for Class I director: Garrey E. Carruthers, Daniel Cooperman, and Frank E. Murray (with one remaining vacant seat in Class I); |
|
(2) |
re-approved the material terms of the performance goals for Section 162(m)(1) awards under the Companys Incentive Compensation Plan; and |
|
(3) |
ratified the appointment of Ernst & Young LLP as the Companys independent registered public accounting firm for 2015. |
Shares were voted on the proposals as follows:
With regard to
Proposal No. 1 for the election of three Class I directors, the stockholders voted as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director |
|
Votes For |
|
|
Votes Against |
|
|
Abstentions |
|
|
Broker Non- Votes |
|
|
% of Votes For |
|
Garrey E. Carruthers |
|
|
43,446,875 |
|
|
|
117,492 |
|
|
|
59,355 |
|
|
|
3,180,916 |
|
|
|
92.8 |
% |
Daniel Cooperman |
|
|
43,445,637 |
|
|
|
118,493 |
|
|
|
59,592 |
|
|
|
3,180,916 |
|
|
|
92.8 |
% |
Frank E. Murray |
|
|
43,445,873 |
|
|
|
118,493 |
|
|
|
59,356 |
|
|
|
3,180,916 |
|
|
|
92.8 |
% |
With regard to Proposal No.2 for the re-approval of the material terms of the performance goals for Section 162(m)(1)
awards under the Company Incentive Compensation Plan, the stockholders voted as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Votes For |
|
Votes Against |
|
|
Abstentions |
|
|
Broker Non-Votes |
|
|
% of Votes For |
|
42,881,823 |
|
|
676,223 |
|
|
|
65,676 |
|
|
|
3,180,916 |
|
|
|
91.6 |
% |
With regard to Proposal No. 3 for the ratification of the appointment of Ernst & Young LLP as the Companys
independent registered public accounting firm for 2015, the stockholders voted as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Votes For |
|
Votes Against |
|
|
Abstentions |
|
|
Broker Non-Votes |
|
|
% of Votes For |
|
46,121,572 |
|
|
623,156 |
|
|
|
59,910 |
|
|
|
0 |
|
|
|
98.5 |
% |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
MOLINA HEALTHCARE, INC. |
|
|
|
|
Date: May 12, 2015 |
|
|
|
By: |
|
/s/ Jeff D. Barlow |
|
|
|
|
|
|
Jeff D. Barlow Chief Legal Officer and
Corporate Secretary |
3
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Molina Healthcare (NYSE:MOH)
Historical Stock Chart
From Apr 2023 to Apr 2024